reference/662691

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/662691

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, N.I.H., Intramural
issn	2045-2322
issueIdentifier	1
pageRange	5662-
publicationName	Scientific Reports
startingPage	5662
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a07f1380dec49a326062ef81e452d9a7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a17a13da33e78be7b43e202cc60bc193
bibliographicCitation	Lochrin SE, Turkbey B, Gasmi B, Schmidt K, Strope JD, Chau CH, Sissung TM, Price DK, Cordes L, Markolovic S, Wood BJ, Pinto PA, McKinney YL, Shih JH, Levy E, Madan R, Dahut W, Choyke PL, Merino M, Figg WD. Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers. Scientific Reports. 2021 Mar 11;11(1):5662. doi: 10.1038/s41598-021-84960-w.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d07150d350af10d793f0f68f87dfc81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e8e4db6908dba2beae219953fbeca85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74d284efb9893585252a028717369bc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c51fa886342b3eaf3f9a5a50b278db86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efe8d6792c8dec6cb41567d52b6e7a2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_199a50761a232dfe7c87fc992856b80e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15b9d3ba54989b27dad06641d408ed31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_434988dd9f44167d3a6822d40f680a46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8471bec55af77aa9e0956edd93ea2a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ed38be02e6d30ab038579eddaeb62ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4130f74e38a34829aa3834e5f189b7f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49c2a6b0a3804b64061b396f168a7908 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_640f58b4ea79c798f6c26fa404e49e0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e79f403715054ab9b0f4d5978728581 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8ae84440603f66dbe628fe5edf89fb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_118255c387e4f842dca7fb81fb88f207 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c7710483fc386f1153840b3fe63c480 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b946e02e2d7b5a0bc535261c63edf9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_890077eddd53aaaaf5cf6bf8b8404dae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf5e90de86036e929d7f43884905f7df
date	2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33707581 https://pubmed.ncbi.nlm.nih.gov/PMC7952731 https://doi.org/10.1038/s41598-021-84960-w
isPartOf	https://portal.issn.org/resource/ISSN/2045-2322 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39356
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/
title	Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
discusses	http://id.nlm.nih.gov/mesh/M0368795 http://id.nlm.nih.gov/mesh/M0029353 http://id.nlm.nih.gov/mesh/M0198899 http://id.nlm.nih.gov/mesh/M000626958
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9961939 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b3d10eb956ff06dc6732f0ade26a205 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa668cfb5a05e25241a052d89a0d398f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91754427

Total number of triples: 54.